File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Cyclin D1, EMS1 and 11q13 amplification in breast cancer

TitleCyclin D1, EMS1 and 11q13 amplification in breast cancer
Authors
Keywords11q13 amplification
Breast cancer
Cortactin/EMS1
Cyclin D1
Oncogenes
Prognostic markers
Issue Date2003
Citation
Breast Cancer Research and Treatment, 2003, v. 78, n. 3, p. 323-335 How to Cite?
AbstractChromosome locus 11q13 is frequently amplified in a number of human cancers including carcinoma of the breast where up to 15% carry this chromosomal abnormality. Originally 11q13 amplification was thought to involve a single amplicon spanning many megabases, but more recent data have identified four core regions within 11q13 that can be amplified independently or together in different combinations. Although the region harbors several genes with known or suspected oncogenic potential, the complex structure of the amplicons and the fact that 11q13 is gene-rich have made definitive identification of specific genes that contribute to the genesis and progression of breast cancer a difficult and continuing process. To date CCND1, encoding the cell cycle regulatory gene cyclin D1, and EMS1, encoding the filamentous actin binding protein and c-Src substrate cortactin, are the favored candidates responsible for the emergence of two of the four amplification cores.
Persistent Identifierhttp://hdl.handle.net/10722/326449
ISSN
2023 Impact Factor: 3.0
2023 SCImago Journal Rankings: 1.267
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorOrmandy, Christopher J.-
dc.contributor.authorMusgrove, Elizabeth A.-
dc.contributor.authorHui, Rina-
dc.contributor.authorDaly, Roger J.-
dc.contributor.authorSutherland, Robert L.-
dc.date.accessioned2023-03-10T02:19:22Z-
dc.date.available2023-03-10T02:19:22Z-
dc.date.issued2003-
dc.identifier.citationBreast Cancer Research and Treatment, 2003, v. 78, n. 3, p. 323-335-
dc.identifier.issn0167-6806-
dc.identifier.urihttp://hdl.handle.net/10722/326449-
dc.description.abstractChromosome locus 11q13 is frequently amplified in a number of human cancers including carcinoma of the breast where up to 15% carry this chromosomal abnormality. Originally 11q13 amplification was thought to involve a single amplicon spanning many megabases, but more recent data have identified four core regions within 11q13 that can be amplified independently or together in different combinations. Although the region harbors several genes with known or suspected oncogenic potential, the complex structure of the amplicons and the fact that 11q13 is gene-rich have made definitive identification of specific genes that contribute to the genesis and progression of breast cancer a difficult and continuing process. To date CCND1, encoding the cell cycle regulatory gene cyclin D1, and EMS1, encoding the filamentous actin binding protein and c-Src substrate cortactin, are the favored candidates responsible for the emergence of two of the four amplification cores.-
dc.languageeng-
dc.relation.ispartofBreast Cancer Research and Treatment-
dc.subject11q13 amplification-
dc.subjectBreast cancer-
dc.subjectCortactin/EMS1-
dc.subjectCyclin D1-
dc.subjectOncogenes-
dc.subjectPrognostic markers-
dc.titleCyclin D1, EMS1 and 11q13 amplification in breast cancer-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1023/A:1023033708204-
dc.identifier.pmid12755491-
dc.identifier.scopuseid_2-s2.0-0038752987-
dc.identifier.volume78-
dc.identifier.issue3-
dc.identifier.spage323-
dc.identifier.epage335-
dc.identifier.isiWOS:000181979400005-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats